4.7 Article

Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging

期刊

BRAIN
卷 144, 期 -, 页码 1684-1696

出版社

OXFORD UNIV PRESS
DOI: 10.1093/brain/awab088

关键词

multiple sclerosis; myelin water imaging; diffusion microstructural modelling; neurodegeneration; demyelination

资金

  1. MSIF-ECTRIMS McDonald fellowship Multiple Sclerosis International Federation (MSIF-ECTRIMS.2019)
  2. Swiss Government Excellence Scholarship [2019.0539]
  3. Swiss National Science Foundation (SNSF) [PP00P3_176984]
  4. Stiftung zur Forderung der gastroenterologischen und allgemeinen klinischen Forschung
  5. European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie project TRABIT [765148]
  6. Conrad N. Hilton foundation [17313]
  7. Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA
  8. Biogen for developing spinal cord MRI
  9. EUROSTAR [E! 113682]

向作者/读者索取更多资源

Damage to both myelin and axons in multiple sclerosis is extensive, both in lesions and normal-appearing tissue. Certain types of lesions exhibit more severe damage to myelin and axons than others, and progressive patients show more extensive axon/myelin damage in the cortex compared to relapsing-remitting patients. Myelin and axon pathology in lesions is associated with disability in patients with clinical deficits and global measures of neuroaxonal damage.
Damage to the myelin sheath and the neuroaxonal unit is a cardinal feature of multiple sclerosis; however, a detailed characterization of the interaction between myelin and axon damage in vivo remains challenging. We applied myelin water and multi-shell diffusion imaging to quantify the relative damage to myelin and axons (i) among different lesion types; (ii) in normal-appearing tissue; and (iii) across multiple sclerosis clinical subtypes and healthy controls. We also assessed the relation of focal myelin/axon damage with disability and serum neurofilament light chain as a global biological measure of neuroaxonal damage. Ninety-one multiple sclerosis patients (62 relapsing-remitting, 29 progressive) and 72 healthy controls were enrolled in the study. Differences in myelin water fraction and neurite density index were substantial when lesions were compared to healthy control subjects and normal-appearing multiple sclerosis tissue: both white matter and cortical lesions exhibited a decreased myelin water fraction and neurite density index compared with healthy (P < 0.0001) and peri-plaque white matter (P < 0.0001). Periventricular lesions showed decreased myelin water fraction and neurite density index compared with lesions in the juxtacortical region ( P < 0.0001 and P < 0.05). Similarly, lesions with paramagnetic rims showed decreased myelin water fraction and neurite density index relative to lesions without a rim (P < 0.0001). Also, in 75% of white matter lesions, the reduction in neurite density index was higher than the reduction in the myelin water fraction. Besides, normal-appearing white and grey matter revealed diffuse reduction of myelin water fraction and neurite density index in multiple sclerosis compared to healthy controls (P < 0.01). Further, a more extensive reduction in myelin water fraction and neurite density index in normalappearing cortex was observed in progressive versus relapsing-remitting participants. Neurite density index in white matter lesions correlated with disability in patients with clinical deficits (P < 0.01, beta = -10.00); and neurite density index and myelin water fraction in white matter lesions were associated to serum neurofilament light chain in the entire patient cohort (P < 0.01, beta = -3.60 and P < 0.01, beta = 0.13, respectively). These findings suggest that (i) myelin and axon pathology in multiple sclerosis is extensive in both lesions and normal-appearing tissue; (ii) particular types of lesions exhibit more damage to myelin and axons than others; (iii) progressive patients differ from relapsing-remitting patients because of more extensive axon/myelin damage in the cortex; and (iv) myelin and axon pathology in lesions is related to disability in patients with clinical deficits and global measures of neuroaxonal damage.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据